Laurus Labs spurts on acquiring additional stake in Laurus Bio
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
Laurus Labs is currently trading at Rs. 376.85, up by 9.00 points or 2.45% from its previous closing of Rs. 367.85 on the BSE.
The scrip opened at Rs. 368.05 and has touched a high and low of Rs. 382.80 and Rs. 367.85 respectively. So far 42998 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 461.95 on 23-Nov-2022 and a 52 week low of Rs. 279.65 on 28-Apr-2023.
Last one week high and low of the scrip stood at Rs. 382.80 and Rs. 366.25 respectively. The current market cap of the company is Rs. 20503.75 crore.
The promoters holding in the company stood at 27.20%, while Institutions and Non-Institutions held 35.04% and 37.76% respectively.
Laurus Labs has completed the acquisition of balance 8,333 equity shares from the promoter group shareholders of Laurus Bio on November 20, 2023. With this acquisition the Company holds 87.59% shareholding (on fully diluted basis) in Laurus Bio.
Laurus Labs is a leading research and development driven pharmaceutical company in India. The company has grown consistently to become one of the leading manufacturers of APIs for anti-retroviral (ARV) and Hepatitis C. It also manufactures APIs in oncology and other therapeutic areas.
